There are all kinds of therapies to cure what ails you. But a new and intriguing approach is bibliotherapy, which dispenses a prescription of literature specifically tailored to a patient's unique circumstances. NPR's Rachel Martin speaks with pioneering bibliotherapist Susan Elderkin.
A new experimental drug is designed to slow down Alzheimer's by protecting brain cells from toxins associated with the disease. That's a different approach from other Alzheimer's drugs, which have tried to eliminate those toxins.